CLOs on the Move

Penumbra

www.penumbrainc.com

 
Penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. We design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. Today we have over 1,300 employees with sales operations in North America, Europe, Latin America, Australia and Asia. Members of the Penumbra team agree that this is where their work has meaning -- we are transforming the treatment of some of the world`s most devastating conditions. Penumbra is ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Seth Schulman
 Vice President, Regulatory Affairs Profile
Johanna Roberts
 Executive Vice President and General Counsel Profile
William Yee
 Head of Intellectual Property (IP) Profile

Similar Companies

Perspectives International

Perspectives International is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NovaSignal

NovaSignal Corp. is a medical technology company whose mission is to save lives by unlocking the hidden power of blood flow data. The company`s FDA-cleared NovaGuide™ Intelligent Ultrasound combines non-invasive ultrasound, robotics, and artificial intelligence to assess real-time cerebral blood flow. Through the use of cloud computing and data analytics services, NovaSignal supports physicians in their clinical decision making, leading to better patient outcomes.

Capistrano Lab Inc

Capistrano Lab Inc is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pearson Dental Supplies Co

Pearson Dental Supplies Co is a Sylmar, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

VALUTEK

VALUTEK is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.